PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Schoen, M.P.* ; Berking, C.* ; Biedermann, T.* ; Buhl, T.* ; Erpenbeck, L.* ; Eyerich, K.* ; Eyerich, S. ; Ghoreschi, K.* ; Goebeler, M.* ; Ludwig, R.J.* ; Schaekel, K.* ; Schilling, B.* ; Schlapbach, C.* ; Stary, G.* ; von Stebut, E.* ; Steinbrink, K.*

COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.

J. Dtsch. Dermatol. Ges. 18, 795-807 (2020)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
The COVID-19 pandemic caused by SARS-CoV-2 has far-reaching direct and indirect medical consequences. These include both the course and treatment of diseases. It is becoming increasingly clear that infections with SARS-CoV-2 can cause considerable immunological alterations, which particularly also affect pathogenetically and/or therapeutically relevant factors. Against this background we summarize here the current state of knowledge on the interaction of SARS-CoV-2/COVID-19 with mediators of the acute phase of inflammation (TNF, IL-1, IL-6), type 1 and type 17 immune responses (IL-12, IL-23, IL-17, IL-36), type 2 immune reactions (IL-4, IL-13, IL-5, IL-31, IgE), B-cell immunity, checkpoint regulators (PD-1, PD-L1, CTLA4), and orally druggable signaling pathways (JAK, PDE4, calcineurin). In addition, we discuss in this context non-specific immune modulation by glucocorticosteroids, methotrexate, antimalarial drugs, azathioprine, dapsone, mycophenolate mofetil and fumaric acid esters, as well as neutrophil granulocyte-mediated innate immune mechanisms. From these recent findings we derive possible implications for the therapeutic modulation of said immunological mechanisms in connection with SARS-CoV-2/COVID-19. Although, of course, the greatest care should be taken with patients with immunologically mediated diseases or immunomodulating therapies, it appears that many treatments can also be carried out during the COVID-19 pandemic; some even appear to alleviate COVID-19.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.664
0.000
26
25
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Neutrophil Extracellular Traps; Cytokine Storm; Checkpoint Blockade; Mycophenolic-acid; Coronavirus; Pathogenesis; Chloroquine; Infections; Thrombosis; Pneumonia
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 1610-0379
e-ISSN 1610-0387
Zeitschrift Journal der Deutschen Dermatologischen Gesellschaft
Quellenangaben Band: 18, Heft: 8, Seiten: 795-807 Artikelnummer: , Supplement: ,
Verlag Blackwell
Verlagsort Chichester
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
PSP-Element(e) G-505490-001
DOI 10.1111/ddg.14169
WOS ID WOS:000555871200001
PubMed ID 32761894
Erfassungsdatum 2020-10-15
[➜Korrektur melden]